Management of pulmonary arterial hypertension.

Hdl Handle:
http://hdl.handle.net/10147/336292
Title:
Management of pulmonary arterial hypertension.
Authors:
Judge, Eoin P; Gaine, Sean P
Affiliation:
National Pulmonary Hypertension Unit, Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
Citation:
Management of pulmonary arterial hypertension. 2013, 19 (1):44-50 Curr Opin Crit Care
Journal:
Current opinion in critical care
Issue Date:
Feb-2013
URI:
http://hdl.handle.net/10147/336292
DOI:
10.1097/MCC.0b013e32835c5137
PubMed ID:
23242212
Abstract:
Pulmonary arterial hypertension (PAH) is a complex disease with a high mortality. Management of this disease is underpinned by supportive and general therapies delivered by multidisciplinary teams in specialist centres. In recent years, a number of PAH-specific therapies have improved patient outcomes. This article will discuss the management of PAH in the context of relevant recently published studies in this area.
Item Type:
Article
Language:
en
Keywords:
MORTALITY
Local subject classification:
PULMONARY ARTERIAL HYPERTENSION
MeSH:
Anticoagulants; Antihypertensive Agents; Combined Modality Therapy; Diuretics; Female; Guidelines as Topic; Humans; Hyperbaric Oxygenation; Hypertension, Pulmonary; Male; Outcome Assessment (Health Care); Patient Selection; Phosphodiesterase 5 Inhibitors; Prostaglandins; Receptors, Endothelin; Registries
ISSN:
1531-7072

Full metadata record

DC FieldValue Language
dc.contributor.authorJudge, Eoin Pen_GB
dc.contributor.authorGaine, Sean Pen_GB
dc.date.accessioned2014-11-27T16:42:59Z-
dc.date.available2014-11-27T16:42:59Z-
dc.date.issued2013-02-
dc.identifier.citationManagement of pulmonary arterial hypertension. 2013, 19 (1):44-50 Curr Opin Crit Careen_GB
dc.identifier.issn1531-7072-
dc.identifier.pmid23242212-
dc.identifier.doi10.1097/MCC.0b013e32835c5137-
dc.identifier.urihttp://hdl.handle.net/10147/336292-
dc.description.abstractPulmonary arterial hypertension (PAH) is a complex disease with a high mortality. Management of this disease is underpinned by supportive and general therapies delivered by multidisciplinary teams in specialist centres. In recent years, a number of PAH-specific therapies have improved patient outcomes. This article will discuss the management of PAH in the context of relevant recently published studies in this area.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Current opinion in critical careen_GB
dc.subjectMORTALITYen_GB
dc.subject.meshAnticoagulants-
dc.subject.meshAntihypertensive Agents-
dc.subject.meshCombined Modality Therapy-
dc.subject.meshDiuretics-
dc.subject.meshFemale-
dc.subject.meshGuidelines as Topic-
dc.subject.meshHumans-
dc.subject.meshHyperbaric Oxygenation-
dc.subject.meshHypertension, Pulmonary-
dc.subject.meshMale-
dc.subject.meshOutcome Assessment (Health Care)-
dc.subject.meshPatient Selection-
dc.subject.meshPhosphodiesterase 5 Inhibitors-
dc.subject.meshProstaglandins-
dc.subject.meshReceptors, Endothelin-
dc.subject.meshRegistries-
dc.subject.otherPULMONARY ARTERIAL HYPERTENSIONen_GB
dc.titleManagement of pulmonary arterial hypertension.en_GB
dc.typeArticleen
dc.contributor.departmentNational Pulmonary Hypertension Unit, Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.en_GB
dc.identifier.journalCurrent opinion in critical careen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.